Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy-Reference-Cited by-同舟云学术

Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy

Published:2024-09 Issue:9 Volume:35 Page:1253-1267.e1
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Kennedy Andrew S.^ORCID,Brown Daniel B.,Fakih Marwan,Jeyarajah Rohan,Jones Suzanne,Liu David^ORCID,Pinato David J.,Sangro Bruno^ORCID,Sharma Navesh K.,Sze Daniel Y.^ORCID,Van Cutsem Eric,Wasan Harpreet S.

Funder

Sirtex Medical Ltd

Publisher

Elsevier BV

Reference88 articles.

1. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial;Vilgrain;Lancet Oncol,2017

2. Phase III multi-centre open-label randomized controlled trial of selective internal radiation therapy (SIRT) versus sorafenib in locally advanced hepatocellular carcinoma: the SIRveNIB study;Chow;J Clin Oncol,2017

3. Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma;Ricke;J Hepatol,2019

4. Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study;Hermann;Radiology,2020

5. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial;Garin;Lancet Gastroenterol Hepatol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma;Journal of Personalized Medicine;2024-07-14